Helsinki, Finland - Royal Philips (NYSE: PHG, AEX: PHIA) The solution combines Silo AI’s computer vision experience and the healthcare experience that Philips offers. The algorithms could generate information that can be used for novel radiotherapy planning purposes such as organ autocontouring and MR-only radiotherapy, which can streamline workflows, reduce repetitive manual work and support patient-centric care in radiotherapy.
We wanted to take our existing AI capabilities to the next level by bringing in expertise from Silo AI. It is a pleasure to collaborate with Silo AI, who has extremely valuable capabilities in applying computer vision to the healthcare domain
Tero Virta
Head of R&D in Radiation Oncology at Philips
– We’re lucky to be able to work with such a long-standing expert in healthcare technology like Philips. Their technological abilities and knowhow have made the collaboration smooth and easy. With Philips, we have the potential to provide our computer vision capabilities into real-world healthcare solutions that scale globally and can improve the lives of thousands of patients, says Peter Sarlin, CEO at Silo AI.
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 70,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.